According to Wallstreetcn, the Nasdaq Biotechnology Index rose more than 1.4% to a record high, with 4D Molecular up 19.44%, Argenx ADR up 16.04%, OmniAb up 13.02%, ARS Pharmaceuticals up 10.44%, and Kyverna Therapeutics up 9.55%, while Evolus fell 4.72%, Neumora Therapeutics fell 5%, Wave Life Sciences fell 5.92%, Humacyte fell 7.31%, Sionna Therapeutics fell 8.51%, Gossamer Bio fell 9.21%, and EyePoint Pharmaceuticals fell 66.98%.